key: cord-0749488-5gar2740
authors: Nilgiriwala, Kayzad; Mandal, Ayan; Patel, Grishma; Mestry, Tejal; Vaswani, Smriti; Shaikh, Ambreen; Sriraman, Kalpana; Parikh, Swapneil; Udupa, Shreevatsa; Chatterjee, Nirjhar; Shastri, Jayanthi; Mistry, Nerges
title: Genome Sequences of Five SARS-CoV-2 Variants from Mumbai, India, Obtained by Nanopore Sequencing
date: 2021-04-15
journal: Microbiol Resour Announc
DOI: 10.1128/mra.00231-21
sha: 1dc6f4edd0ab39b1318811868c59e18030b3a494
doc_id: 749488
cord_uid: 5gar2740

We report here the genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants from five coronavirus disease 2019 (COVID-19) patients in Mumbai, India. Viral genomic RNA was isolated from nasopharyngeal swabs and/or respiratory particles from the masks of the patients. Genomic variant analysis determined 8 to 22 mutations, and the variants belong to lineages previously associated with Indian variants.

W ith an increasing rate of infection that has reached nearly 122 million globally and 11.5 million in India as of 18 March 2021, the coronavirus disease 2019 (COVID-19) pandemic has grown dramatically over a span of 1 year. The genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (family Coronaviridae, genus Betacoronavirus) help us to provide insights for fighting against the disease, which has so far been estimated to cause 2.06 million deaths worldwide (https://covid19.who.int/).

In this study, we present the genome sequence of SARS-CoV-2 viruses from five COVID-19 patients, collected between August and September 2020 from Kasturba Hospital for Infectious Diseases in Mumbai, India. The study was undertaken between June and September 2020 after approval by the Institutional Research Ethics Committee of the Foundation for Medical Research (FMR), Mumbai (FMR/IREC/TB/01/ 2020), and the Institutional Review Board of Kasturba Hospital for Infectious Diseases (IRB-09/2020). Four out of the five samples were obtained from nasopharyngeal swabs (NPS), whereas one sample (CMP-19/2020) was obtained from a modified N-95 mask worn by the patient (1). The patients ranged in age from 17 to 68 years old and had presented with mild to moderate symptoms of COVID-19, including fever, cough, and weakness, with their cycle threshold (C T ) values ranging from 20 to 31. The RNA from NPS was extracted using the MagMax viral/pathogenic nucleic acid isolation kit via the KingFisher Flex system (Thermo Fisher Scientific, USA), while the RNA from the mask was extracted using the QIAamp viral RNA minikit (Qiagen, Germany) as per a protocol used earlier (1). The cDNA was synthesized using the high-capacity cDNA reverse transcription kit (Thermo Fisher Scientific).

Whole-genome sequencing was conducted using the ARTIC amplicon sequencing protocol (2) and GridION sequencer (Oxford Nanopore Technologies, UK). Base calling was performed using Guppy v3.5.1 in high accuracy mode (3) . The processed reads were subjected to filtering using the fieldbioinformatics v1.1.3 pipeline (https://github .com/artic-network/fieldbioinformatics). The variants identified were further annotated using SnpEff v4.3 (4). A range of 8 to 22 mutations were observed in the genome sequences of the five variants (Table 1 ). All five variants had the D614G mutation in the 

a Asterisks represent the presence of a mutation. spike protein (5) and c14408t in the ORF1ab gene. All tools were run with default parameters unless otherwise specified. About 0.3 to 1.15 million reads were generated, with coverage in the range of 5,000 to 12,000Â. Consensus sequences for each of the samples were generated using mpile-up in SAMtools v1.10 (6). The genomic GC content ranged from 38 to 40%, and the length of sequences ranged from 29,694 to 29,866 bp, covering 99.3 to 99.8% of the reference genome.

A phylogenetic analysis was conducted (7); the sequences were clustered using Augur v6.3.0 and aligned using MAFFT v7.471. Maximum likelihood trees were generated using IQ-TREE v1.6.12 and visualized using Auspice v2.0 (8) (Fig. 1) . Four out of the five variants belonged to clade 20B, and one belonged to clade 20A. PANGOLIN v2.1.6 (www.github .com/cov-lineages/pangolin) was used to determine the lineages-two variants belonged to lineage B.1.1.306, and three variants belonged to lineages B.1.36, B.1.1.32, and B.1.1.281. All four lineages were previously associated with other Indian variants (https:// cov-lineages.org/lineages). Sequencing of additional Indian viral variants in the future will be useful for understanding transmission, immune resistance, and vaccine efficacy in the population toward mitigation of a possible second wave of COVID-19 in India.

Data availability. The data from this study can be found under GISAID accession numbers EPI_ISL_779703, EPI_ISL_779705, EPI_ISL_779706, EPI_ISL_779708, and EPI_ ISL_779710 (the sequences can be downloaded from GISAID at https://www.gisaid .org/); GenBank accession numbers MW645473, MW645474, MW645475, MW645476, and MW645477; SRA accession numbers SRR13892481, SRR13892480, SRR13892479, SRR13892478, and SRR13892477; and BioProject accession number PRJNA707397. 

Non-invasive sampling using an adapted N-95 mask: an alternative method to quantify SARS-CoV-2 in expelled respiratory samples and its implications in transmission

nCoV-2019 sequencing protocol 2020. protocols.io, Berkeley

Performance of neural network basecalling tools for Oxford Nanopore sequencing

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w 1118 ; iso-2; iso-3

Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus

Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools

GISAID: global initiative on sharing all influenza data-from vision to reality

Nextstrain: real-time tracking of pathogen evolution

We thank Godrej Agrovet Limited (Mumbai), Zoroastrian Charity Funds of Hong Kong, Canton, and Macao, and the Vashketu Foundation (Mumbai) for providing financial support for this study.We also thank Genotypic Technology Pvt. Ltd., Bangalore, for sequencing the samples using a GridION sequencer (Oxford Nanopore Technologies).